Références
1. Wuttke W et al. Maturitas. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. 2003 Mar 14;44 Suppl 1:S67-77.
2. Radowicki S et al. Effectiveness and safety of the treatment of menopausal syndrome with Cimicifuga racemosa dry extract. Ginekol Pol. 2006. Sep;77(9):678-83.
3. Nappi RE et al. Efficiency of Cimicifuga racemosa on climacteric complaints : a randomized study versus low-dose transdermal estradiol. Gynecol Endocrinol. 2005. Jan ;20(1) :30-5.
4. Mahady GB. Black cohosh (Actea/Cimicifuga racemosa): review of the clinical data for safety and efficacy in menopausal symptoms. Treat Endocrinol. 2005;4(3): 177-84.
5. Geller SE, Studee L. Botanical and dietary supplements for mood and anxiety in menopausal women. Menopause. 2007. May-Jun;14(3 Pt 1):541-9
6. Booth NL et al. The chemical and biologic profile of a red clover (Trifolium pratense L.) phase II clinical extract. J Altern Complement Med. 2006. Mar ;12(2) :133-9
7. Overk CR et al. Comparison of the in vitro estrogenic activities of compounds from hops (Humulus lupulus) and red clover (Trifolium pratense). J Agric Food Chem. 2005. Aug 10;53(16):6246-53.
8. Imhof M et al. Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women. Maturitas. 2006. Aug 20;55(1):76-81.
9. Tice JA et al. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Colver Extract (ICE) Study: a randomized controlled trial. JAMA. 2003 Jul 9;290(2):207-14.
10. Miquel J et al. Menopause : a review on the role of oxygen stress and favorable effects of dietary antioxydants. Arch Gerontol Geriatr. 2006 May-Jun;42(3):289-306.
11. Pou KM et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation. 2007 Sep 11;116(11):1234-41.
12. Beitner H. Randomized, placebo-controlled, double blind study on the clinical efficiency of a cream containing 5 % alpha-lipoic acid related to photoageing of facial skin. Br J Dermatol. 2003 Oct;149(4):841-9.
13. Pansini F et al. Oxidative stress, body fat composition, and endocrine status in pre-and postmenopausal women. Menopause. 2007 Aug 9.
14. Nielsen FH et al. Dietary magnesium deficiency induces heart rhythm changes, impairs glucose tolerance, and decreases serum cholesterol in post menopausal women. J Am Coll Nutr. 2007 Apr;26(2):121-32.
15. Hachul de Campos H et al. Sleep disturbances, oxidative stress and cardiovascular risk parameters in postmenopausal women complaining of insomnia. Climacteric. 2006 Aug;9)4): 312-9.
16. Fenichel P. Xénoestrogènes et cancer du sein : De nouveaux facteurs de risque accessibles à la prévention ? Reprod. hum. horm. 2005, vol. 18, no 1-2 (56 ref.), pp. 34-42.
17. Sohoni P, Sumpter JP. Several environmental oestrogens are also anti-androgens. J Endocrinol 1998 Sep ;158(3) : 327-39.
18. Olea N et al. Inadvertent exposure to xenoestrogens. Eur J Cancer Prev 1998 Feb ; 7 Suppl 1 : 17-23
19. www.naturaldatabase.com
20. www.passeportsante.net
21. www.hc-sc.gc.ca/dhp-mps/prodnatur/applications/licen-prod/monograph/mono_list_f.php#m
Sites d'intérêt à consulter
Viazen Pharma Inc. ©2007-2010 |
English / Français |